Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease

Movement Disorders

Volumn 26, Issue 5, 2011, Pages 819-823

  Mata, Ignacio F ^a,b   Yearout, Dora ^a,b   Alvarez, Victoria ^c   Coto, Eliecer ^c   de Mena, Lorena ^c   Ribacoba, Renee ^d   Lorenzo Betancor, Oswaldo ^e,f   Samaranch, Lluis ^e   Pastor, Pau ^e,f,g   Cervantes, Sebastian ^e,f   Infante, Jon ^h   Garcia Gorostiaga, Ines ⁱ   Sierra, Maria ^h   Combarros, Onofre ^h   Snapinn, Katherine W ^j   Edwards, Karen L ^j   Zabetian, Cyrus P ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d HOSPITAL ÁLVAREZ BUYLLA   (Spain)

^e UNIVERSITY OF NAVARRA   (Spain)

^f UNIVERSITY CLINIC OF NAVARRA   (Spain)

^g CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^h HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

ⁱ HOSPITAL DE GALDAKAO   (Spain)

^j UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

Genome wide; Parkinson's disease; Replication

Indexed keywords

ALPHA SYNUCLEIN; PARK16 PROTEIN; PARK17 PROTEIN; PARK18 PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SELECTION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MARKER GENE; ONSET AGE; PARKINSON DISEASE; POPULATION STRUCTURE; PRIORITY JOURNAL; SAMPLE SIZE; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; DNA REPLICATION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN; TAU PROTEINS;

EID: 79955113404     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23642     Document Type: Article

References (22)

1. Goris A, Williams-Gray CH, Clark GR, et al. Tau and alpha-synuclein in susceptibility to, and dementia in, Parkinson's disease. Ann Neurol 2007; 62: 145-153.
2. Maraganore DM, de Andrade M, Elbaz A, et al. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA 2006; 296: 661-670.
3. Zabetian CP, Hutter CM, Factor SA, et al. Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Ann Neurol 2007; 62: 137-144.
4. Di Fonzo A, Wu-Chou YH, Lu CS, et al. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan. Neurogenetics 2006; 7: 133-138.
5. Edwards TL, Scott WK, Almonte C, et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann Hum Genet 2010; 74: 97-109.
6. Pankratz N, Wilk JB, Latourelle JC, et al. Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 2009; 124: 593-605.
7. Satake W, Nakabayashi Y, Mizuta I, et al. Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nat Genet 2009; 41: 1303-1307.
8. Simon-Sanchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet 2009; 41: 1308-1312.
9. Hamza TH, Zabetian CP, Tenesa A, et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat Genet 2010; 42: 781-785.
10. Mata IF, Shi M, Agarwal P, et al. A SNCA Variant Associated with Parkinson's Disease and Plasma α-Synuclein Level. Arch Neurol 2010; 67: 1350-1356.
11. Tan EK, Kwok HK, Tan LC, et al. Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus. Neurology 2010; 75: 508-512.
12. Zabetian CP, Yamamoto M, Lopez AN, et al. LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Mov Disord 2009; 24: 1034-1041.
13. Zollner S, Pritchard JK. Overcoming the winner's curse: estimating penetrance parameters from case-control data. Am J Hum Genet 2007; 80: 605-615.
14. Evseeva I, Nicodemus KK, Bonilla C, Tonks S, Bodmer WF. Linkage disequilibrium and age of HLA region SNPs in relation to classic HLA gene alleles within Europe. Eur J Hum Genet 2010; 18: 924-932.
15. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904-909.
16. Epstein MP, Allen AS, Satten GA. A simple and improved correction for population stratification in case-control studies. Am J Hum Genet 2007; 80: 921-930.
17. Kimmel G, Jordan MI, Halperin E, Shamir R, Karp RM. A randomization test for controlling population stratification in whole-genome association studies. Am J Hum Genet 2007; 81: 895-905.
18. Gayan J, Galan JJ, Gonzalez-Perez A, et al. Genetic structure of the Spanish population. BMC Genomics 2010; 11: 326.
19. Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. Clin Microbiol Rev 2009; 22: 370-385.
20. Jang H, Boltz DA, Webster RG, Smeyne RJ. Viral parkinsonism. Biochim Biophys Acta 2009; 1792: 714-721.
21. Marrie RA. When one and one make three: HLA and EBV infection in MS. Neurology 2008; 70: 1067-1068.
22. Garcia-Gorostiaga I, Sanchez-Juan P, Mateo I, et al. Glycogen synthase kinase-3 beta and tau genes interact in Parkinson's and Alzheimer's diseases. Ann Neurol 2009; 65: 759-761.